Last updated: 23 August 2022 at 9:01pm EST

Alejandro Galindo M.B.A., M.S. Net Worth




The estimated Net Worth of Alejandro Galindo is at least $4.78 Million dollars as of 22 August 2022. Mr Galindo owns over 4,615 units of Mannkind Corp stock worth over $4,763,470 and over the last 4 years he sold MNKD stock worth over $17,768.

Mr S MNKD stock SEC Form 4 insiders trading

Mr has made over 6 trades of the Mannkind Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 4,615 units of MNKD stock worth $17,768 on 22 August 2022.

The largest trade he's ever made was buying 36,900 units of Mannkind Corp stock on 28 February 2022 worth over $99,999. On average, Mr trades about 8,041 units every 57 days since 2020. As of 22 August 2022 he still owns at least 777,075 units of Mannkind Corp stock.

You can see the complete history of Mr Galindo stock trades at the bottom of the page.





Mr. Alejandro Galindo M.B.A., M.S. biography

Alejandro Galindo M.B.A., M.S. is the Chief Commercial Officer at Mannkind Corp.



How old is Mr S?

Mr S is 49, he's been the Chief Commercial Officer of Mannkind Corp since . There are 18 older and 4 younger executives at Mannkind Corp. The oldest executive at Mannkind Corp is Kent Kresa, 82, who is the Independent Chairman of the Board.

What's Mr S's mailing address?

Alejandro's mailing address filed with the SEC is 1, Casper Street, Danbury, Fairfield County, Connecticut, 06810, United States.

Insiders trading at Mannkind Corp

Over the last 20 years, insiders at Mannkind Corp have traded over $14,187,027 worth of Mannkind Corp stock and bought 107,212,962 units worth $2,707,661,837 . The most active insiders traders include Alfred E Mann, Juergen Martens, and David Thomson. On average, Mannkind Corp executives and independent directors trade stock every 27 days with the average trade being worth of $3,220,647. The most recent stock trade was executed by Stuart A Tross on 3 September 2024, trading 25,000 units of MNKD stock currently worth $156,500.



What does Mannkind Corp do?

mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.



What does Mannkind Corp's logo look like?

Mannkind Corp logo

Complete history of Mr Galindo stock trades at Mannkind Corp

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
22 Aug 2022 Alejandro Galindo
EVP Endocrine Business Unit
Sale 4,615 $3.85 $17,768
22 Aug 2022
777,075
31 Jul 2022 Alejandro Galindo
EVP Endocrine Business Unit
Buy 5,000 $2.93 $14,650
31 Jul 2022
781,690
28 Feb 2022 Alejandro Galindo
EVP Endocrine Business Unit
Buy 36,900 $2.71 $99,999
28 Feb 2022
576,690
31 Jan 2022 Alejandro Galindo
EVP Endocrine Business Unit
Buy 2,334 $3.17 $7,399
31 Jan 2022
540,320
30 Jul 2021 Alejandro Galindo
EVP Endocrine Business Unit
Buy 5,000 $2.99 $14,950
30 Jul 2021
547,602
8 Dec 2020 Alejandro Galindo
EVP Endocrine Business Unit
Buy 34,602 $2.89 $100,000
8 Dec 2020
398,602


Mannkind Corp executives and stock owners

Mannkind Corp executives and other stock owners filed with the SEC include: